Posted inPress Release

Fort Worth clinical-stage oncology company issued patent

FORT WORTH, Texas–(BUSINESS WIRE)–NanOlogy LLC, a clinical-stage oncology company, announced today issuance of a US patent titled: Local Delivery of Antineoplastic Particles in Combination with Systemic Delivery of Immunotherapeutic Agents for the Treatment of Cancer. The patent (11,583,499) is valid in the US until November 25, 2038, and has corresponding filings globally. It adds to an […]

Sign In

We've recently sent you an authentication link. Please, check your inbox!

Sign in with a password below, or sign in using your email.

Get a code sent to your email to sign in, or sign in using a password.

Enter the code you received via email to sign in, or sign in using a password.

Subscribe to our newsletters:

OR

Privacy Policy